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SUSCEPTIBILITY OF Cebus apella MONKEY (PRIMATES: CEBIDAE) TO EXPERIMENTAL 
Leishmania (L.) infantum chagasi-INFECTION
Liliane Almeida CARNEIRO(1), Fernando Tobias SILVEIRA(1,2), Marliane Batista CAMPOS(1), Maria do Carmo de Oliveira BRÍGIDO(1), Claudia Maria C. GOMES(3), 
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SUMMARY
In Amazonian Brazil, the Cebus apella monkey (Primates: Cebidae) has been associated with the enzootic cycle of Leishmania 
(V.) shawi, a dermotropic parasite causing American cutaneous leishmaniasis (ACL). It has also been successfully used as animal 
model for studying cutaneous leishmaniasis. In this work, there has been investigated its susceptibility to experimental Leishmania (L.) 
infantum chagasi-infection, the etiologic agent of American visceral leishmaniasis (AVL). There were used ten C. apella specimens, 
eight adult and two young, four males and six females, all born and raised in captivity. Two experimental infection protocols were 
performed: i) six monkeys were inoculated, intra-dermal via (ID), into the base of the tail with 2 x 106 promastigotes forms from the 
stationary phase culture medium; ii) other four monkeys were inoculated with 3 x 107 amastigotes forms from the visceral infection 
of infected hamsters by two different via: a) two by intravenous via (IV) and, b) other two by intra-peritoneal via (IP). The parameters 
of infection evaluation included: a) clinical: physical exam of abdomen, weigh and body temperature; b) parasitological: needle 
aspiration of the bone-marrow for searching of amastigotes (Giemsa-stained smears) and promastigotes forms (culture medium); c) 
immunological: Indirect fluorescence antibody test (IFAT) and, Delayed-type hypersensitivity (DTH). In the six monkeys ID inoculated 
(promastigotes forms) all parameters of infection evaluation were negative during the 12 months period of follow-up. Among the four 
monkeys inoculated with amastigotes forms, two IV inoculated showed the parasite in the bone-marrow from the first toward to the 
sixth month p.i. and following that they cleared the infection, whereas the other two IP inoculated were totally negative. These four 
monkeys showed specific IgG-antibody response since the third month p.i. (IP: 1/80 and IV: 1/320 IgG) toward to the 12th month 
(IP: 1/160 and IV: 1/5120). The DTH-conversion occurred in only one IV inoculated monkey with a strong (30 mm) skin reaction. 
Considering these results, we do not encourage the use of C. apella monkey as animal model for studying the AVL.
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INTRODUCTION
Actually, there are in Brazil eight well recognized Leishmania spp. 
belonging to the subgenera Viannia (L. braziliensis, L. guyanensis, L. 
lainsoni, L. shawi, L. lindenbergi and L. naiffi) and Leishmania (L. 
amazonensis and L. infantum chagasi) which can give rise to clinical 
manifestations of human leishmaniasis. From these, L. (L.) i. chagasi 
has been regarded as the principal etiologic agent of American visceral 
leishmaniasis (AVL), whereas others are implicated as etiologic agents of 
different clinical forms of American cutaneous leishmaniasis (ACL)9,19,20. 
The best way to prevent these forms of human leishmaniasis, either 
ACL or AVL, would be through the use of an efficient vaccine with 
capacity of developing human immune protection against these diseases. 
In this way, considering some ethical reasons which prohibit the use of 
humans in scientific assays with any health integrity risk, there has been 
encouragement for the development of animal models that can serve to 
study the pathology and/or immunology induced by these leishmanial 
parasites in humans. Thus, in viewing of the great physiologic and 
phylogenetic proximity between non-human primates with man1, there is 
significant amount of works either in the Old World or in the New World 
demonstrating that these animals may mimic the clinical-immunological 
manifestations found in human leishmaniasis17.
As examples on this issue, it should be regarded that some neotropical 
monkeys have prior been successfully used as experimental models 
for studying AVL, as following: Callithrix jacchus12, Aotus trivirgatus 
(=Aotus infulatus)4 and Saimiri sciureus5. In a similar way, the African 
green monkey Cercopithecus aethiops6 and the Presbytes entellus 
monkey14,15,16 have also been used for studying the Old World’s visceral 
leishmaniasis.
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In this context, it should also be emphasized the successful results by 
the use of the neotropical Cebus apella monkey (Primates: Cebidae) as 
experimental model for studying, in Brazil, the cutaneous leishmaniasis 
due to L. (V.) lainsoni, L. (V.) braziliensis and L. (L.) amazonensis23,24. 
This monkey species has also been incriminated as a wild reservoir of L. 
(V.) shawi in the Amazon region, Brazil, where this leishmanial parasite 
is considered an important agent of ACL8,25. Based in these findings, 
it was also investigated in vivo the susceptibility of C. apella monkey 
to experimental infection by L. (L.) i. chagasi, the etiological agent of 
AVL; the parasitological, clinical and immunological findings of this 
investigation are discussed in the present work.
MATERIAL AND METHODS
Local of experiment: This study was carried out in the Leishmaniasis 
Laboratory at the Parasitology Department of Evandro Chagas Institute 
(ECI, Ministry of Health, Brazil), in cooperation with the National 
Center of Primates (NCP, Ministry of Health, Brazil), both in Ananindeua 
municipality, Pará State, and the Pathology Laboratory of Infectious 
Diseases (“LIM-50”), Pathology Department, School of Medicine of the 
São Paulo University (“USP”), São Paulo State, Brazil.
Experimental animals: There were used ten (10) specimens, eight 
adult and two young, four males and six females, of the neotropical 
monkey C. apella (Primates: Cebidae), all born and raised in captivity 
from the National Center of Primates (NCP, Ministry of Health, Brazil), 
in good environmental and dietetic conditions.
Parasite: The L. (L.) i. chagasi-strain (MCAO/BR/2003/M22697/
Pará State) used in this experiment was provided by the Leishmaniasis 
Laboratory of Evandro Chagas Institute (ECI, Ministry of Health, Brazil), 
where the parasite is maintained into the criobank at temperature of -180 oC.
Maintenance of L. (L.) i. chagasi-strain virulence: In order to 
guarantee the continued virulence of L. (L.) i. chagasi-strain, the 
stationary phase promastigotes from Difco B45 blood-agar culture 
medium (WALTON et al. 1977)26 were re-inoculated, intra-peritoneal 
via, in laboratory hamster (Mesocricetus auratus). 
Inoculum preparation from stationary phase culture promastigotes: 
Three months later, the amastigotes forms from the visceral infection 
of hamsters were transferred to the liquid culture medium RPMI-1640 
(Sigma-Aldrich, USA) supplemented with 10% fetal bovine serum (FBS) 
(CULTILAS); 100 U/mL of penicillin-G; 100 µg/mL gentamicin; 2mM 
L-glutamine and 10 mM hepes. The parasites were then cultivated at 
25 ºC and the stationary phase promastigotes forms, established by way 
of a growth-curve, showed to be best used after seven days of culture. 
The final concentration of stationary phase promastigotes suspension 
was, approximately, 2 x 107 /mL and the inoculum per animal was 0.1 mL 
(2 x 106 parasites).
Experimental infection protocol: There were carried out two 
experiments: i) in the first, six monkeys were inoculated, intra-dermal via 
(ID), into the base of the tail (at the dorsal surface) with 2 x 106 L. (L.) i. 
chagasi-promastigotes forms from the stationary phase culture medium 
RPMI-1640; ii) in the second, other four monkeys were inoculated with, 
approximately, 3 x 107 amastigotes forms from the visceral infection 
of infected hamsters through two different via: a) two monkeys were 
inoculated by intravenous via (IV) and, b) other two by intra-peritoneal 
via (IP).
Evaluation parameters of experimental infection evolution: For all 
evaluations, the experimental monkeys were promptly anesthetized with 
an intramuscular injection of ketamine (10 mg/kg) plus xylazine (1 mg/
kg) solution (2:1 ratio) with the dose of 15 mg/kg7,13. The experimental 
infection evaluations of monkeys were at monthly intervals and included 
the following criteria:
1) Clinical: physical evaluation of the abdomen, the weight and the 
body temperature;
2) Specific laboratory: needle aspiration of the bone-marrow (Fig. 1) 
for the parasitological searching of amastigotes forms in Giemsa-stained 
smears, and promastigotes forms in the blood-agar culture medium 
Difco B4526;
3) Specific immune response: a) Indirect fluorescence antibody 
test (IFAT)10,21,22 with a specific anti-monkey conjugate (Bethyl, USA) 
looking for the specific IgG-antibody response; and, b) Delayed-type 
hypersensitivity (DTH)18,21,22 with a homologous L. (L.) i. chagasi-
promastigotes antigen (106 parasites/intra-dermal dose), searching for 
the T-cell immune response. However, considering some speculation on 
the capacity of DTH-skin reaction in producing immunogenic effect in 
the receptors11, this assay was only realized once time, at the end (11th 
month) of the period of experimental infection evaluation. 
Control of the experimental infections: As a control of each 
experimental infection in C. apella monkey, there was used the 
same type of inoculum, such as, 2 x 106 promastigotes forms or 3 
x 107 amastigotes forms of L. (L.) i. chagasi, for inoculating, by 
intraperitoneal via, into two hamsters (each type of inoculum) that 
were followed-up till three to four months post-inoculation for the 
developing of visceral infection.
Data analysis: The statistically significant differences on the criteria 
used for evaluating the susceptibility of C. apella to experimental L. 
(L.) i. chagasi-infection were obtained by the use of the Bio-Estat 4.0 
software2. The X2 was used to compare these differences with p < 0.05 
considered to be as significant.
Ethical approval: This study was approved by the Ethics Committee 
in Animal Research of Evandro Chagas Institute (ECI), Surveillance 
Secretary of Health, Ministry of Health, Brazil, with the protocol number 
10/2004 (CEPAN/IEC/SVS/MS/Brazil).
RESULTS
In the six C. apella monkeys ID inoculated into the base of the tail 
with 2 x 106 promastigotes forms (stationary phase) of L. (L.) i. chagasi 
there was not observed till the 12th month pos inoculation (p.i.) any clinical 
sign which could be related to the active infection (symptomatic) in these 
monkeys, as well as there were not found neither amastigotes forms in 
the Giemsa-stained smears nor promastigotes forms in the blood-agar 
culture medium (Difco B45) of the parasite from the bone-marrow. 
Besides this, there were not demonstrated in none of these monkeys 
neither the development of the humoral immune response characterized 
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by the specific IgG-antibody response (IFAT) against to L. (L.) i. chagasi, 
nor the DTH-skin reaction (specific T-cell immune response) (Fig. 2).
On the other side, concerning those four C. apella monkeys 
inoculated with 3 x 107 amastigotes forms (from the visceral infection 
of hamsters) of L. (L.) i. chagasi it was observed, till 12th month p.i., in 
the two monkeys, IV inoculated, a significant mean weight decrease of 
501gr in relation to other two monkeys, IP inoculated, which presented 
a weight decrease of only 258gr. In relation to the body temperature, 
there was not found any difference on the mean temperature (38.5 ºC) 
regarding these two monkeys groups (IV x IP).
As far as the parasitological research is concerned, it was 
demonstrated the presence of L. (L.) i. chagasi from the bone-marrow 
either in the Giemsa-stained smears (amastigotes forms) or in the 
blood-agar culture medium Difco B45 (promastigotes forms) since 
the first toward to the 6th month p.i. in the two monkeys IV inoculated; 
from the seven toward to the 12th month p.i. there was the clearance of 
Fig. 1 - The needle aspiration proceeding of the bone-marrow from a specimen of C. apella 
monkey, following anesthesia. 
Fig. 2 - The delayed-type hypersensitivity (DTH) skin reactions in the anterior surface of the forearm of C. apella monkey: a) IP inoculated (negative); b) IV inoculated (negative); c) IV 
inoculated (30 mm skin infiltration = positive); and, d) control negative. 
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the parasite in the bone-marrow of these two monkeys. On the other 
hand, in the two monkeys IP inoculated the parasitological research 
was totally negative.
Regarding the specific IgG-antibody response (IFAT), it was 
demonstrated the seroconversion of all four monkeys inoculated with 
amastigotes forms since the third month p.i., with 1/80 for the monkeys 
IP inoculated, and 1/320 for the monkeys IV inoculated. The evolution 
of the IgG-antibody response showed, in the two monkeys IP inoculated, 
an increase to 1/320 at the 5th month p.i.; following this, the IgG-antibody 
response came down to 1/160 at the 6th month p.i. and remained in this 
level (1/160) till the last month (12th) of evaluation. On the other hand, 
in the two monkeys IV inoculated there was a progressive increase in the 
IgG-antibody response toward to the 11th month p.i. going up to 1/5,120 
and keeping in this level till the 12th month p.i. 
As it was prior concerned, the DTH-skin reaction was only realized 
at the 11th month p.i. and regarding the two monkeys IP inoculated this 
revealed results totally negative; in the case, however, of the two monkeys 
IV inoculated, one was also negative whereas the other showed a very 
strong response (30 mm of skin infiltration) in comparison with the 
negative control (Fig. 2). 
At last, it must also be confirmed that all four hamsters (two equal 
groups) used as control animal for the experimental infections in C. apella 
monkey with L. (L.) i. chagasi have developed visceralizing infection 
following IP inoculation with the two types of inoculum used in the 
monkeys, as follows; the first group inoculated with 2 x 106 stationary 
phase promastigotes forms have developed clinical signs of disease after 
3 to 4 months p.i.; the second group inoculated with 3 x 107 amastigotes 
forms have developed clinical signs of disease after two months p.i., 
confirming the infectivity of these inoculum.
DISCUSSION
The use of non-human primates as animal model for studying the 
visceral leishmaniasis has been the target of many studies either in the Old 
World or in the New World, aiming to establish an experimental biological 
system which may evaluate the clinical and immunopathological 
events inherent to the process of interaction between the pathogenic 
viscerotropic leishmanial parasites (L. donovani, L. infantum and L. i. 
chagasi) and the humoral and T-cell immune responses of man. However, 
although some works have successfully documented the use of a given 
monkey species, it has been noted that in most situations the successful 
result was only achieved following the use of an exaggerated inoculum 
of either amastigotes or promastigotes forms of one of these pathogenic 
viscerotropic Leishmania spp., which characterizes an experimental 
approach excessively artificial and, consequently, rather different from 
the natural transmission of disease by phlebotomine sand fly.
In this way, it should be highlighted the work of GICHERU et 
al.6 which used 8 x 107 promastigotes forms of L. (L.) donovani to 
experimentally infect, by intra-dermal via, the African green monkey, 
Cercopithecus aethiops. In this experiment, from nine monkeys 
inoculated with this parasite, four developed clinical manifestations 
of visceral leishmanisis and have died following eighteen months p.i. 
Regarding yet the visceral leishmaniasis of the Old World, BINHAZIM3 
have also challenged the African green monkey, C. aethiops, with 107 
amastigotes forms/kg of weight, by IV via, of L. (L.) donovani and L. 
(L.) infantum. As a result, these authors have observed several clinical 
manifestations similar to that of man, as well as some hematological 
disorders and the development of a specific IgG-antibody response. Other 
example concerning the use of non-human primates as animal model for 
studying the Old World visceral leishmaniasis was that of ANURADHA1, 
which used the Indian monkey, Presbytis entellus, for experimental 
infecting it with 108 amastigotes forms of L. (L.) donovani, by IV via. The 
clinical and immunological results of this experiment have encouraged 
these authors to consider the Indian monkey, P. entellus, as a promising 
animal model for studying the Old World visceral leishmaniasis due to 
L. (L.) donovani. Nevertheless, as prior reported, these relative successful 
findings were only achieved by the use of a high inoculum of amastigotes 
or promastigotes forms of these pathogenic viscerotropic parasites, as 
well as the artificial IP or IV ways for inoculation of these parasites, 
characterizing these experiments as much artificial. 
With respect to the experiments regarding L. (L.) i. chagasi, the 
etiologic agent of New World visceral leishmaniasis, it should be 
emphasized the pioneer work of MARSDEN et al.12 whom inoculated, 
by IV via, a pool of the liver and spleen (amastigotes forms) of infected 
hamsters in the neotropical monkey Callithrix jacchus. In that year, 
CHAPMAN & HANSON5 have also used the IV via for developing 
the experimental infection of the neotropical monkey Saimiri sciureus 
with an inoculum of approximately 3 x 107 amastigotes forms of L. (L.) 
i. chagasi. Lastly, BRODERSON et al.4 have studied the susceptibility 
of the monkey Aotus trivirgatus (= Aotus infulatus) to experimental 
infection due to L. (L.) i. chagasi by inoculating, IV via, approximately, 
32.5 x 106 amastigotes forms of the parasite in eight specimens of this 
monkey; following three months p.i. six monkeys have died and two 
have survived from the visceral infection.
With basis on the above comments, it seems reasonable to speculate 
that susceptibility of a given monkey species to these pathogenic 
viscerotropic leishmanial parasites would be best analyzed by using 
an experimental infection protocol with intra-dermal inoculation of 
promastigotes forms of these parasites with a concentration not too high 
like those used in the works discussed above. In this way, regarding that 
in the present work there were used two infection protocols, one with 
promastigotes forms ID inoculated and, another with amastigotes forms 
IP and IV inoculated, then the results will be discussed separately. First, 
with respect to the experimental infection realized with intra-dermal 
inoculation of promastigotes forms of L. (L.) i. chagasi, it should be 
emphasized that the suspension concentration of the parasite (2 x 107) 
was equivalent to those successfully used in prior studies with the same 
monkey species, C. apella, for studying the development of experimental 
cutaneous leishmaniasis by L. (V.) braziliensis, L. (V.) lainsoni and L. 
(L.) amazonensis23,24. Thus, considering that this experimental infection 
protocol has prior promoted satisfactory results with dermotropic 
Leishmania spp. in the C. apella monkey, it is believed that the present 
findings with promastigotes forms of L. (L.) i. chagasi, which revealed 
totally negative in terms of clinical, parasitological and immmunological 
evaluation parameters, should likely be credited to a natural resistance 
of C. apella monkey against to experimental L. (L.) i. chagasi-infection.
Second, with regards to the experiments carried out with IP and IV 
inoculation of 3 x 107 amastigotes forms of L. (L.) i. chagasi, the results 
obtained have shown that this inoculum concentration was incapable 
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of promoting a patent experimental infection in the C. apella monkey 
when this inoculum was IP injected. Otherwise, when the inoculum 
was IV injected, it was confirmed the patent infection in the bone-
marrow of the two monkeys by demonstrating the amastigotes forms 
of the parasite in Giemsa-stained smears, as well as the promastigotes 
forms in the blood-agar culture medium B4526, since the first toward to 
the 6th month p.i. Following this time point (6th month p.i.), it was not 
possible to demonstrate the bone-marrow infection till the end of the 
experiment follow-up (12th month p.i.), revealing that the two C. apella 
monkeys were capable to promote the clearance of infection from the 
bone-marrow. Besides this, there were not detected neither clinical 
sign (hepatosplenomegaly) nor symptom (fever) that could suggest the 
presence of active infection in the monkeys, even in the presence of a 
progressive IgG-antibody response against to L. (L.) i. chagasi, which 
raised up to 5,120 at the 12th month p.i. Supporting this idea, it was 
confirmed in one of the two monkeys IV inoculated a very strong DTH-
skin reaction (30 mm diameter), characterizing the development of T-cell 
immune response against to L. (L.) i. chagasi-infection, which represents 
one of major resistance immunological mechanisms.
Taking all these comments in account, it is believed that C. apella 
monkey might have a resistant natural T-cell immune mechanism against 
to L. (L.) i. chagasi-infection, once even the two monkeys IV inoculated 
with 3 x 107 amastigotes forms of L. (L.) i. chagasi have developed 
temporary infection of the bone-marrow, they were capable of promoting 
the clearance of infection, clearly demonstrating the ability of inhibiting 
the L. (L.) i. chagasi-growth into the macrophage; thus, contradicting the 
use of C. apella monkey as a suitable animal model for studying AVL.
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RESUMO
Susceptibilidade do macaco Cebus apella (Primata: Cebidae) à 
infecção experimental por Leishmania (L.) infantum chagasi
Na Amazônia Brasileira, o macaco Cebus apella (Primata: Cebidae) 
tem sido associado com o ciclo enzoótico da Leishmania (V.) shawi, um 
parasito dermotrópico causador da Leishmaniose Tegumentar Americana 
(LTA). Ele tem sido também empregado com sucesso como modelo 
experimental para estudo da leishmaniose tegumentar. Neste trabalho, foi 
investigada sua susceptibilidade à infecção experimental por Leishmania 
(L.) infantum chagasi, o agente etiológico da Leishmaniose Visceral 
Americana (LVA). Foram usados dez espécimes de C. apella oito adultos 
e dois jovens, quatro machos e seis fêmeas, todos nascidos e criados em 
cativeiro. Dois protocolos de infecção experimental foram feitos: i) seis 
macacos foram inoculados por via intradérmica (ID), na base da cauda 
com 2x106 formas promastigotas em fase estacionária de crescimento; ii) 
outros quatro macacos foram inoculados com 3x107 formas amastigotas 
de infecção visceral de hamsteres por duas vias diferentes: a) dois por via 
intravenosa (IV) e, b) outros dois pela via intraperitoneal (IP). A avaliação 
da infecção incluiu parâmetros: clínico: exame físico do abdômen, peso 
e temperatura corporal; b) parasitológico: aspirado de medula óssea 
por agulha para procura de amastigotas (esfregaço corado por Giemsa) 
e formas promastigotas (meio de cultura); c) imunológico: Reação de 
Imunofluorescência Indireta (RIFI) e, resposta de hipersensibilidade 
tardia (DTH). Nos seis macacos inoculados ID (formas promastigotas) 
todos os parâmetros de avaliação da infecção foram negativos durante o 
período de 12 meses. Entre os quatro macacos inoculados com formas 
amastigotas, dois inoculados IV mostraram parasitos na medula óssea do 
primeiro ao sexto mês p.i. e em seguida houve a resolução da infecção, no 
entanto os outros dois inoculados IP foram totalmente negativos. Esses 
quatro macacos apresentaram resposta específica de anticorpo IgG desde 
o terceiro mês p.i. (IP: 1/80 e IV: 1/320) até o décimo segundo mês (IP: 
1/160 e IV: 1/5120). A conversão DTH ocorreu em apenas um macaco 
inoculado IV com uma forte reação na pele (30 mm). Considerando esses 
resultados, nós não recomendamos o uso do macaco C. apella como 
modelo animal para estudo da LVA.
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